Re: Zenith Update: Feedback

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

chicagoest

Rank: President [?]

Points: 1974 [?]

Votes: 20 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Update: Feedback

in response to

Zenith Update: Feedback

SanFrancisco99

posted on Jun 21, 2016 10:25AM

SanFran

Thank you for that - We are getting closer and if these novel therapies are game changers, once this starts to move, imho it will unfold quickly